CIK: 0001577524 · Show all filings
Period: Q2 2024 (← Previous) (Next →)
Filing Date: Aug 14, 2024
Total Value ($000): $592,421 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| BIIB | BIOGEN INC | 643,000 | $149,060 | 25.2% | $278.12 | -21.9% | COM | 09062X103 |
| INVA | INNOVIVA INC | 7,277,000 | $119,343 | 20.1% | $13.02 | +19.2% | COM | 45781M101 |
| IRWD | IRONWOOD PHARMACEUTICALS INC | 16,390,000 | $106,863 | 18.0% | $11.52 | -38.6% | COM CL A | 46333X108 |
| GILD | GILEAD SCIENCES INC | 1,103,282 | $75,696 | 12.8% | $58.12 | +8.6% | COM | 375558103 |
| CYTK | CYTOKINETICS INC | 1,110,000 | $60,140 | 10.2% | $64.95 | -7.1% | COM NEW | 23282W605 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 410,483 | $56,511 | 9.5% | $108.95 | +25.9% | COM | 64125C109 |
| — | AMARIN CORP PLC | 24,850,623 | $17,097 | 2.9% | $1.48 | — | SPONS ADR NEW | 023111206 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 1,094,168 | $6,762 | 1.1% | $5.10 | +8.1% | COM | 09058V103 |
| — | VOR BIOPHARMA INC | 618,000 | $618 | 0.1% | $43.10 | — | COM | 929033108 |
| — | REGULUS THERAPEUTICS INC | 185,183 | $331 | 0.1% | $2.07 | — | COM | 75915K309 |